Health Care Costs and Utilization of Dabigatran Compared with Warfarin for Secondary Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation

Nai Fang Chi, Ye Wang, Li Nien Chien, Shu Chen Chien, Yu Ko*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Health Care Costs and Utilization of Dabigatran Compared with Warfarin for Secondary Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology